References
- Bai, Z. D., Hu, F. F., Rosenberger, W. F. (2002). Asymptotic properties of adaptive designs for clinical trials with delayed response. Annals of Statistics 30:122—139.
- Chow, S. C., Chang, M. (2008). Adaptive design methods in clinical trials: A review. Orphanet Journal of Rare Diseases 3:11.
- Cook, T., DeMets, D. L. (2010). Review of draft FDA adaptive design guidance. Journal of Biopharmaceutical Statistics 20:1132–1142.
- Hey, S. P., Kimmelman, J. (2015a). Are outcome-adaptive allocation trials ethical? Clinical Trials 12(2):102–106.
- Hey, S. P., Kimmelman, J. (2015b). Rejoinder. Clinical Trials 12(2):125–127.
- Hu, F. F., Rosenberger, W. F. (2003). Optinality, variability, power: Evaluating response-adaptive randomization procedures for treatment comparisons. Journal of the American Statistical Association 98:671–678.
- Hu, F. F., Rosenberger, W. F. (2006). The Theory of Response-Adaptive Randomization in Clinical Trials. Hoboken, NJ: John Wiley and Sons.
- Hu, F. F., Zhang, L. X. (2004). Asymptotic properties of double adaptive biased coin designs for multi-treatment clinical trials. Annals of Statistics 32:268—301.
- Kim, E. S., Herbst, R. S., Wistuba II, Lee, J. J., Blumenschein, G. R., Tsao, A., Stewart, D. J., Hicks, M. E., Erasmus, J., Gupta, S., Alden, C. M., Liu, S., Tang, X., Khuri, F. R., Tran, H. T., Johnson, B. E., Heymach, J. V., Mao, L., Fossella, F., Kies, M. S., Papadimitrakopoulou, V., Davis, S. E., Lippman, S. M., Hong, W. K. (2011). The BATTLE trial: Personalizing therapy for lung cancer. Cancer Discovery 1(1):44–53.
- Korn, E. L., Freidlin, B. (2011). Outcome-adaptive randomization: Is it useful? Journal of Clinical Oncology 29:771—776.
- Lee, J. J. (2015). Commentary on Hey and Kimmelman. Clinical Trials 12(2):110–112.
- Lee, J. J., Chen, N., Yin, G. S. (2012). Worth adapting? Revising the usefulness of outcome-adaptive randomization. Clinical Cancer Research 18:449s8—4507.
- Lee, J. J., Feng, L. (2005). Randomized phase II designs in cancer clinical trials: Current status and future directions. Journal of Clinical Oncology 23(19):4450–4457.
- Rosenberger, W. F., Lachin, J. M. (2002). Randomization in Clinical Trials: Theory and Practice. New York: John Wiley and Sons.
- Rosenberger, W. F., Oleksandr, S., Hu, F. F. (2012). Adaptive randomization for clinical trials. Journal of Biopharmaceutical Statistics 22:719–736.
- Rosenberger, W. F., Vidyashankar, A. N., Agarwal, D. K. (2001). Covariate-adjusted response-adaptive designs for binary response. Journal of Biopharmaceutical Statistics 11:227–236.
- Thall, P ., Fox, P., Wathen, J. (2015). Statistical controversies in clinical research: Scientific and ethical problems with adaptive randomization in comparative clinical trials. Annals of Oncology 26:1621–1628.
- Thall, P. F., Wathen, J. K. (2007). Practical Bayesian adaptive randomization in clinical trials. European Journal of Cancer 43:859–866.
- Thompson, W. R. (1933). On the likelihood that one unknown probability exceeds another in view of the evidence of two samples. Biometrika 25:275–294.
- Wason, J., Trippa, L. (2014). A comparison of Bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials. Statistics in Medicine 33:2206–2221.
- Wei, L. J., Durham, S. (1978). The randomized play-the-winner rule in medical trial. Biometrics 73:840–843.
- Zelen, M. (1969). Play the winner rule and the controlled clinical trial. Journal of the American Statistical Association 64:131–146.
- Zelen, M. (1974). The randomization and stratification of patients to clinical trials. Journal of Chronic Diseases 27:365–375.
- Zhang, L., Rosenberger, W. F. (2006). Response-adaptive randomization for clinical trials with continuous outcomes. Journal of the American Statistical Association 62:562–569.
- Zhang, L., Rosenberger, W. F. (2007). Response-adaptive randomization for survival trials: The parametric approach. Journal of the Royal Statistical Society: Series C (Applied Statistics) 56:153–165.
- Zhang, L. X., Chan, W. S., Hu, F. F. (2007). A generalized drop-the-loser urn for clinical trials with delayed responses. Statistica Sinica 17:387–409.